A B S T R A C T We studied the effects of i.v. 2 mg/kg morphine sulfate (MS) on coronary blood flow and resistance, left ventricular (LV) diameter and pressure (P), rate of change of pressure (dP/dt), and dP/dt/P in conscious dogs. An initial transient reduction in coronary vascular resistance, associated with increases in heart rate, dP/dt, dP/dt/P, and reductions in LV enddiastolic and end-systolic size were observed. This was followed by a prolonged increase in mean coronary vascular resistance, lasting from 5 to 30 min, while heart rate, arterial pressure, and LV end-diastolic diameter returned to control levels and dP/dt/P remained slightly but significantly above control. At 10 min, late diastolic coronary flow had fallen from 44+3 ml/min to a minimum level of 25±3 ml/min, while late diastolic coronary resistance had risen from 1.68±0.10 to 3.04±0.28 mm Hg/ml/min. Morphine also induced substantial coronary vasoconstriction when heart rate was held constant. Neither the MS-induced coronary vasoconstriction nor the positive inotropic response was abolished by bilateral adrenalectomy. The positive inotropic response of MS was reversed after beta blockade, but not the coronary vasoconstriction. Alpha receptor blockade abolished the late coronary vasoconstrictor effects of morphine, and only dilatation occurred. In anesthetized dogs MS failed to produce late coronary vasoconstriction. Coronary vasoconstriction was not observed in conscious dogs after a respiratory-depressant dose of morphine, 10 mg/kg i.v. Smaller doses of MS, 0.25 mg/kg every 15 min, produced significant coronary vasoconstriction after a total dose of 0.75 mg/kg in the conscious dogs.
INTRODUCTION
The clinical utility of opiates has been established for centuries. The most common opium alkaloid, morphine sulfate (MS),' constitutes one of the most important therapeutic agents available for treatment of the pain and pulmonary edema that occur during the course of acute myocardial infarction. Moreover, it is commonly administered as a preanesthetic, or as the sole anesthetic for cardiovascular surgical procedures (1, 2) , and as an analgesic and narcotic in a wide variety of conditions. In addition, morphine and other opiates are commonly involved in drug addiction. Despite its prevalent use, the effects of morphine on the heart and coronary vessels are poorly understood. Morphine is thought to have little effect on systemic hemodynamics (1, 3, 4) , although both a transient decrease (5) , or no change (1, 3, 4) in systemic vascular resistance as well as reduced (6) (7) (8) and enhanced (9) myocardial contractility have been observed. Despite its frequent use in patients with myocardial ischemia, little is known about the effects of morphine on the coronary vascular bed. Earlier studies concluded that it had little effect (8) or that it dilated the coronary bed (3, (10) (11) (12) (13) . However, only one of these studies was conducted in the intact animal (3), and none measured coronary blood flow continuously or took into account changes in cardiac 1 Abbreviations used in this paper: dP/dt, rate of change of pressure; LV, left ventricular; MS, morphine sulfate.
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The goal of the present study was to clarify the effects of morphine on the normal coronary circulation and left ventricle of the conscious dog. It was deemed important to assess the effects of morphine in the healthy, conscious animal, since other cardioactive pharmacologic agents, e.g., norepinephrine (14) , dopamine (15) , and cardiac glycosides (16, 17) , have been shown to exert differing effects on the heart and coronary circulation in the presence and absence of general anesthesia. Since the effects of a pharmacologic agent on the coronary circulation cannot be assessed without appreciation of factors influencing myocardial metabolic demand, the effects of MS on instantaneous and continuous measurements of coronary blood flow and resistance were examined in combination with simultaneous measurements of heart rate, arterial pressure, left ventricular (LV) pressures (P), and dimensions and indices of myocardial contractility.
The mechanism of action of the drug was analyzed by comparing its effects (a) in large and small doses; (b) in spontaneous rhythm and with heart rate constant; (c) in the presence and absence of alpha and beta adrenergic receptor blockades; (d) in the conscious and anesthetized states; and (e) before and after bilateral adrenalectomy.
METHODS
15 mongrel dogs, weighing between 22 and 35 kg, were anesthetized with 30 mg/kg pentobarbital Na. Through a thoracotomy in the fifth left intercostal space, miniature pressure gauges were implanted within the left ventricle through a stab wound in the apex, ultrasonic diameter transducers were implanted on opposing endocardial surfaces of the left ventricle, Doppler ultrasonic or electromagnetic flow transducers were placed around the left circumflex coronary artery, stimulator electrodes were sutured to the left atrium, and heparin-filled Tygon catheters were chronically implanted in the thoracic aorta. Three of these dogs underwent bilateral adrenalectomy at a later date, performed under pentobarbital Na anesthesia, 30 mg/kg, through bilateral flank incisions. The animals after adrenalectomy were maintained on 1 mg desoxycorticosterone acetate and 10 mg cortisone acetate daily.
The miniature LV pressure gauges were calibrated be- system has been previously described in detail (18, 19) . It has a reliable electrical zero (18, 19) , and in these experi- In all experiments in the conscious state, the dogs spontaneously breathed room air. Propranolol was administered 10 min before morphine. Phentolamine was administered 5 min before morphine. Phenoxybenzamine was administered 30 min before morphine. The adequacy of beta adrenergic blockade was tested with 5 ,ug isoproterenol i.v., and the adequacy of alpha adrenergic blockade was tested with 10 ,g norepinephrine i.v. before and after completion of the experiment. The effects of both morphine vehicles were tested on separate days and found not to be significant.
The effects of smaller doses of morphine were studied in six dogs with heart rate maintained constant. After control records were obtained, MS was administered in an i.v. bolus, at a dose of 0.25 mg/kg every 15 min for 1 h until a total dose of 1 mg/kg had been administered. In three dogs the effects of a larger dose, 10 mg/kg infused i.v. over 5 min were examined.
Data were recorded on a multichannel tape recorder and played back on a direct writing oscillograph. Electronic resistor-capacitor filters having a 2-s time constant were used to derive mean arterial blood pressure and mean left circumflex coronary blood flow. Mean and late diastolic coronary resistances were calculated as the quotients of mean and late diastolic arterial pressures and coronary blood flows, respectively. Continuous records of dP/dt and dD/dt, i.e. velocity, were derived from LV pressure and diameter signals, with electronic differentiators having frequency responses of 60 and 30 Hz, respectively. A triangular wave signal with known slope (rate of change) was substituted for the pressure signal to calibrate the dP/dt channel directly.
The effects of morphine on peak and isolength velocity (dD/dt) and on peak LV dP/dt and the quotient of dP/dt and developed pressure (LV isovolumic minus end-diastolic pressure), i.e., (dP/dt) /P, were assessed. The same level of pressure that occurred during isometric contraction, before and after morphine, was used for this calculation, and dP/dt and P were determined at that level of pressure. These techniques for evaluating the myocardial contractile state have been described in detail previously (14, 15, 17, 21) .
The responses to morphine were analyzed statistically with standard errors of the mean and paired t tests (22) . RESULTS Infusion of 2 mg/kg MS produced a biphasic response. Initially a transient excitement response, reaching a peak at 21 min, was observed. By 5 min the animals were tranquil and remained so for the duration of the experiments (30 min). While data were collected continuously, effects at 21, 5, 10, 15, and 30 min after infusion were compared to the control levels recorded before morphine administration. When 0.25 mg/kg MS TIME (min) AFTER MS 10 15 Effects of 2 mg/kg MS in normal conscious dogs with heart rate held constant Systemic effects. Heart rate was maintained constant at 118±6 beats/min during the control period and again between 5 and 30 min after morphine, but not before 5 min after morphine, because spontaneous rates were too high. Mean and late diastolic arterial pressures did not change significantly from control after morphine.
Left ventricle. Morphine did not affect peak LV pressure and significantly reduced end-diastolic pressure at 5 and 10 min. As was observed in spontaneous rhythm, LV end-diastolic diameter was significantly decreased (P < 0.05) at 5 min, but not from 10 to 30 min. Peak dP/dt was significantly elevated from 15 to 30 min. dP/dt/P also rose (P < 0.01) at 15 min and remained elevated at 30 min (Fig. 2) . Peak and isolength velocity rose at 30 min (P < 0.05) from controls of 75±3 and 73±3 to 82±4 and 79±3 mm/s.
Coronary dynamics. As in the dogs with spontaneous rhythm, late diastolic coronary flow was significantly lower 5-30 min after morphine; at 10 min it had fallen from a control level of 57+6 to 31+5 ml/min (P < 0.01). Late diastolic coronary resistance was increased significantly above control from 5 to 30 min (Fig. 3) ; at 10 min it had risen from 1.41+0.15 to 2.79±0.30 mm Hg/ml/min (P < 0.01). Thus, the major effects of morphine, i.e., a reduction in coronary flow and an increase in coronary resistance from 5 to 30 min and the later increases in contractility (from 15 to 30 min), occurred with heart rate constant as well as in spontaneous rhythm.
Effects of 2 mg/kg MS in normal conscious dogs after beta adrenergic blockade with heart rate constant Systemic effects. When heart rate was maintained constant at 120±3 beats/min, mean and late diastolic arterial pressures did not change significantly from control after morphine.
Left ventricle. Peak LV pressure did not change significantly from control throughout the experiment. LV end-diastolic and end-systolic diameters fell significantly after morphine, as had occurred in the unblocked dogs (Fig. 2) ; LV end-diastolic diameter was significantly reduced at 5 and 10 min after morphine. A correspondingly significant decrease in LV end-diastolic pressure occurred as well. Beta adrenergic blockade abolished the morphine-induced increases in dP/dt and dP/dt/P. Actually a negative inotropic effect was observed, as reflected by reductions in dP/dt/P, which fell from 52±4 to 38±5 s-1 (P <0.01) at 5 min and remained depressed significantly through 30 min (Fig. 2) TIME (min) AFTER MS FIGURE 3 Average ± SEM values from the sustained coronary dynamic effects of morphine, 2 mg/kg, i.v. In conscious dogs with heart rate constant and without autonomic blockade (12 dogs) prolonged coronary vasoconstriction was observed. In contrast, in conscious dogs after combined beta and alpha adrenergic blockade (6 dogs) and with heart rate constant, prolonged coronary dilatation occurred. *P < 0.05 change from control.
(P <0.01) from 65±4 and 60±4 to 52±4 and 49±3 mm/s, respectively. Coronary dynamics. The reductions in mean and late diastolic coronary flows and the increases in mean and late diastolic coronary resistances induced by morphine at 10-30 min were not significantly different after beta receptor blockade as compared to responses in the absence of blockade.
Thus, beta receptor blockade reversed the positive inotropic response to morphine, but not the prolonged period of coronary vasoconstriction.
Effects of 2 mg/kg MS in the normal conscious dogs after alpha and beta adrenergic blockades with heart rate constant Systemic effects. With heart rate maintained constant at 116±5 beats/min, mean arterial pressure fell after morphine from 104±4 to 51+7 mm Hg at 5 min (P < 0.01) and remained below control for the duration of the experiment. Similarly, late diastolic arterial pressure decreased and remained depressed (P < 0.01).
Left ventricle. Peak LV pressure fell at 5 min and remained depressed. Both LV end-diastolic and end-systolic diameters were persistently below control (P < 0.05) from 5 to 30 min after morphine. Peak dP/dt and dP/dt/P remained essentially at control levels of 2,250+ 100 mm Hg/s and 45+2 s', respectively, throughout the experiment. Peak and isolength velocities remained at control levels of 68±4 and 65±4 mm/s as well.
Coronary dynamics. The morphine-induced coronary vasoconstriction was abolished by the addition of alpha adrenergic blockade. Late diastolic coronary flow fell from 62±8 to 49±7 ml/min (P < 0.01) at 5 min and remained significantly depressed at 10 min, but not at 15-30 min. At no point did late diastolic coronary resistance rise above control; in fact, it decreased from 1.57+0.16 to 0.91±0.16 mm Hg/ml/min (P < 0.05) at 5 min and remained depressed for the remainder of the experiment (Fig. 3) . Mean coronary flow and resistance followed a similar pattern.
Thus, with heart rate constant and with sufficient beta adrenergic blockade to prevent the augmentation of contractility, the addition of alpha adrenergic blockade reversed the coronary vasoconstrictor response to one of sustained coronary vasodilation.
Effects of 2 mg/kg MS in conscious dogs after adrenalectomy
The effects of morphine were qualitatively similar before and after recovery from bilateral adrenalectomy (Table II) . In all three dogs, peak dP/dt and dP/dt/P were moderately increased (Table II) . As in the dogs hefore adrenalectomy, morphine induced a marked increase in mean and late diastolic coronary resistances from 10 to 30 min after morphine infusion (Table II) .
Effects of 2 mg/kg MS in normal anesthetized dogs
Systemic effects. The response to morphine after pentobarbital was quite similar to the response after beta and alpha adrenergic blockades. Mean arterial pressure fell significantly (P < 0.01) from 5 to 30 min after morphine, from 87±4 mm Hg to 49±9 mm Hg at 5 min, and remained depressed throughout the 30-min observation period. Heart rate increased from 123±4 beats/min to 162±22 at 2j min and remained elevated for 10 min.
Left ventricle. Peak LV pressure fell (P < 0.05) at 5 min and remained depressed for 30 min. Both LV enddiastolic and end-systolic diameters remained below control levels from 5 to 30 min after morphine (P < 0.01) at all points. Contractility, as reflected in dP/dt/P, did not change significantly from control.
Coronary dynamics. Late diastolic coronary flow did not change significantly after the morphine infusion, and late diastolic coronary resistance fell from 1.53+ 0.14 to 0.77±0.03 (P < 0.01) at 5 min and remained below control at 10 min, but returned to control at 15-30 min (Fig. 4) .
Thus, the response to the same dose of morphine was different in the dogs after general anesthesia, in that the fall in arterial pressure and the rise in heart rate were greater and more sustained, and coronary resistance did not increase.
Effects of 0.25 mg/kg MS every 15 min in the normal conscious dog
With heart rate constant, small doses of morphine had no significant effect on mean arterial pressure, peak dP/dt, dP/dt/P, LV dimensions, or late diastolic arterial pressure. However, at 45 min after a total dose of 0.75 mg/kg of morphine had been administered, a significant reduction in late diastolic coronary flow, from 49+4 ml/min to 43±4 ml/min (P < 0.01) was observed. Coronary flow remained significantly depressed at 60 min. Similarly, with the same dose, late diastolic coronary resistance increased from a control level of 1.76±0.15 mm Hg/ml/min to 2.12±0.20 mm Hg/ml/min at both 45 and 60 min (P < 0.01) (Fig. 5) .
Thus, a significant reduction in coronary flow and rise in coronary resistance occurred with a much smaller dose of morphine as well.
Effects of 10 mg/kg morphine in the normal conscious dog In three dogs a relatively large dose of morphine (10 mg/kg, i.v.) was given, which exerted a mild respira- (5, 23, 24) , it is thought to exert little effect on the normal circulation, as reflected by alterations in heart rate, arterial pressure, cardiac output, and systemic vascular resistance (1, 3, 4) . Except for a transient in- 5 The average ±.SEM changes from control are shown for LV end-diastolic diameter, dP/dt/P, late diastolic arterial pressure, coronary flow, and resistance after small doses of morphine, i.e., 0.25 mg/kg every 15 min (6 dogs). At 45 and 60 min significant reductions in coronary flow and increases in coronary resistance were observed, while other parameters remained constant. crease in heart rate and fall in arterial pressure produced by a relatively large dose of i.v. morphine sulfate, 2 mg/kg, no significant sustained effect on heart rate or arterial pressure was observed in the present study as well. In contrast to the trivial effects on pressure and heart rate, an important coronary vasoconstrictor action was observed. This vasoconstrictor response was not altered by habituation, since similar responses were observed in three animals studied on three separate occasions. Earlier studies conducted in isolated perfused hearts suggested that morphine had little effect on the coronary bed (8) or resulted in dilatation (10) (11) (12) (13) The second possibility, i.e., a direct vasoconstrictor action, was considered unlikely, on the one hand because morphine is known to dilate peripheral vessels when injected intra-arterially (26, 27) , and on the other because the bulk of evidence indicating that morphine dilates the coronary vessels is based on studies in which morphine is administered directly either to isolated perfused hearts or isolated coronary rings (10) (11) (12) (13) . More importantly, morphine failed to constrict the coronary vessels after alpha adrenergic blockade, and in fact caused vasodilatation under these circumstances. This finding argues against the possibility of a direct action unless it is postulated that morphine activates alpha adrenergic receptors in the coronary vessels directly.
It is more likely that morphine's vasoconstrictor effects are due to activation of alpha adrenergic receptors through stimulation of the sympathetic nervous system. Coronary vasoconstriction mediated by alpha adrenergic activation has been -observed previously in our laboratory, when either dopamine or norepinephrine was administered intravenously to conscious dogs (14, 15) .
The sympathetically induced coronary vasoconstriction observed in the conscious animals could have been due to central or peripheral activation of the sympathetic nervous system or to the release of adrenal catecholamines. The latter effect is known to occur after morphine (28) . However, since bilateral adrenalectomy did not prevent this vasoconstriction, release of adrenal catecholamines could not have been solely responsible.
Pilot experiments, not presented in the present study, demonstrated that morphine dilated the coronary bed after alpha adrenergic blockade alone. Since beta adrenergic-mediated increases in contractility also occurred, it was not clear whether this coronary dilatation was due to a direct effect of morphine on coronary vessels or secondarily to the positive inotropic response. Therefore, it was decided to conduct the alpha adrenergic blockade experiments in the presence of partial beta adrenergic blockade as well. However, a dose of propranolol resulting in a relatively complete beta blockade was not selected, since under these circumstances morphine elicited a negative inotropic response, which would tend to reduce myocardial oxygen requirements and thereby cause coronary constriction. Accordingly, the responses to morphine after alpha blockade were examined in the presence of an incomplete blocking dose of propranolol, 0.5 mg/kg, where changes in contractility would not complicate the interpretation of the results of these experiments. In these experiments, conducted at a constant heart rate, without a significant change in myocardial contractility, and at a reduced pressure and cardiac size, morphine elicited substantial coronary vasodilation (Fig. 3) . This vasodilation may have been due to several possible mechanisms: (a) a direct effect of morphine on coronary vessels (b) an autoregulatory mechanism in response to the fall in arterial pressure; or (c) release of histamine by morphine (29 Effects of morphine on cardiac contractility. How morphine affects the myocardial contractile state remains controversial. Studies in papillary muscle preparations indicate that morphine exerts a direct negative inotropic effect, while the present investigation in the intact animal indicates a positive inotropic action, mediated through beta adrenergic receptors. This finding should not be interpreted to indicate that morphine does not cause direct depression of contractility, as reported from studies in isolated cardiac muscle preparations (6) (7) (8) , since after the beta adrenergic effects were prevented by propranolol, morphine did elicit a slight negative inotropic effects (Fig. 2) . Thus, it appears that morphine induces a complex reaction, the beta adrenergic effects slightly overshadowing any direct negative inotropic action of the drug. A previous study by Vasko, Henney, Brawley, Oldham, and Morrow, also found a positive inotropic effect with morphine and attributed it solely to release of adrenal catecholamines (9) . While the latter may contribute to the positive inotropic response to morphine, it is not the sole mechanism, since morphine also increased contractility after adrenalectomy in the present study. Thus, as with the alpha adrenergic coronary vasoconstrictor effects of morphine, the beta adrenergically-mediated increases in contractility were at least in part mediated by sympathetic nerve activation. The increases in dP/dt/P and velocity of myocardial fiber shortening that occurred after morphine in the present study most likely represented a positive inotropic response, since these responses could be abolished with propranolol on the one hand, and since the increases in dP/dt/P and velocity occurred when preload and afterload, which could influence these measurements, had already returned to control levels, on the other.
Effects of morphine on cardiac size. The beneficial effects of morphine in the therapy of acute pulmonary edema are attributed to its sedative action and to a reduction in venous return due to peripheral venous pooling (5, 23, 24) . A reduction in venous return due to venous pooling would tend to reduce cardiac preload, i.e., end-diastolic size. This effect was observed in the present study only early after morphine administration. The reduction in cardiac size was also partially due to a slight reduction in afterload and to the accompanying tachycardia, which also reduces diastolic filling time (31) .
In conclusion, morphine induces a transient reduction in cardiac size and a more prolonged beta adrenergically mediated increase in myocardial contractility. In the face of this moderate increase in contractility, morphine elicits substantial and prolonged coronary vasoconstriction with doses that do not cause respiratory depression, hypoxia, or C02 retention. It is difficult to extrapolate from the results of this study, conducted in conscious dogs with normal coronary vessels, to a different situation in man with diseased coronary arteries, where morphine has been consistently observed to produce a salutary effect. The effects of morphine could be different in the ischemic heart, where coronary vessels are dilated due to the intense local hypoxia caused by impaired coronary perfusion, or where the central sympatholytic (26) and ganglionic blocking (30) effects of the drug may assume greater importance.
